Find Businesses & Services

Science for Organizations in Cedar Knolls, New Jersey

Science for Organizations's Website

(201) 818-1761

156 Terrace Drive
Cedar Knolls, NJ 7927

http://scifororg.com

Map & Directions

Company Description:

SciForOrg.com - Emphasizing Innovative Thinking in the Biotechnology and Pharmaceutical Industries

Services Offered:

Scifororg.com Fda Approval Data Analysis Gastroenterology Pharmaceuticals Consulting
Scientific Manuscripts Presentations Biotechnology Media Services Advertising Not Elsewhere Classified

Web Results:

[View the detailed results...
Back to Case Study 338. Gardner J.D., Sloan S., Robinson M., Miner P.B. Jr. Heartburn severity can predict pathologic oesophageal reflux in gastro-oesophageal reflux patients treated with a proton pump inhibitor . Aliment Pharmacol Ther 18:133-140, 2003. ...
Characterizing important...
Prev Study . Next Study Characterizing a way to prevent drug-induced gastric pathology Pozen, Inc., wanted to determine how much gastric acidity had to be reduced by famotidine in order to prevent the gastroduodenal pathology caused by a particular nonsteroidal anti-inflammatory drug (NSAID). SFO an...
Irving Consulting Group
Prev . Next IRVING CONSULTING GROUP P.O. Box 258 Pluckemin, NJ 07978 Phone: 908-725-5992 Fax: 908-725-6947 Web: http://www.irvingconsulting.com Irving Consulting Group (ICG) is led by Irving K. Hwang, Ph.D., a statistical consultant with more than 30 years' experience in global new drug development....
Science For Organizations - Emphasizing Innovative Thinking in...
Science for Organizations focuses on developing novel approaches to data analysis; and uses these approaches to design studies that help clients understand the full potential of their pharmaceutical products. We specialize in designing clinical trials that bring cutting-edge science to drug developm...
Collaborating on the...
Next Study Collaborating On the Drug Development Process Eisai and Janssen Pharmaceutica formed a strategic partnership to seek Food and Drug Administration (FDA) approval to market rabeprazole, a new proton pump inhibitor, that reduces gastric acid secretion. Knowledge about the pathophysiology of ...

Business Information:

Business Sector:Residential, Commercial
Found any discrepancies in your company profile? Request to update the information